Global healthcare company Randox, which is headquartered in Co. Antrim and has key R&D, engineering and manufacturing facilities in both Co. Antrim and Co. Donegal, has been named in The US-Ireland Top 50 Companies, to be announced today, Friday 16 June, at the New York/New Belfast conference in Manhattan.
With a focus on the transatlantic operations building bridges between the two countries, the awards celebrate those bringing business in Ireland to global heights in the belief that by doing so they are embedding peace for future generations.
The 50 honourees will be announced at a gala event hosted by the Irish Echo, the USA’s largest and most widely read Irish American weekly paper, at Pier A, Harbor House.
The tenth annual celebration will be addressed by Constance Hunter, Chief Economist of KPMG and Daniel Dromm, NYC City Council member and Chair of the Education Committee, and takes place as part of the two-day conference. This prestigious event highlights the progress and prosperity of both cities, and looks optimistically to the future while celebrating our shared past.
Movie makers, scientists, tech companies and engineers have been among those who have received the plaudit in recent years. They have included the all-conquering production company, HBO; leading law firm A&L Goodbody; pioneers in scientific imaging Andor Technology and the New York Stock Exchange.
This year’s US-Ireland Top 50 has proven to be just as illustrious with Randox Laboratories, Northern Property, Norwegian Airlines, and Bank of Ireland as just some of the companies being recognised for their success.
Editor of the Irish Echo, Ray O’Hanlon, who will host Friday’s event, said the awards were an acknowledgment of the unique bonds between the two nations.
“The unmistakable and unbreakable bonds between Ireland and the United States have proven a key element in Ireland’s progression, both in terms of peace and prosperity. Those bonds grow ever stronger when underpinned by economic growth and business relationships. With the Ireland-US Top 50 we acknowledge those companies whose transatlantic operations support that ongoing development and welcome them to this illustrious list of business beacons.”
Dr. Peter FitzGerald, Founder and Managing Director of Randox Laboratories, commented;
“The US is one of our most important markets and we have been exporting our diagnostic products there since the early 1980s. We have seen substantial success in this market and have secured for example, key clinical chemistry analyser contracts in Ivy League Institutions such as Yale University School of Medicine and Harvard University.
“Our diversification into the veterinary, research, forensic and food safety sectors has enabled our operations in the US to expand further still, and due to this increasing demand for Randox innovations, we are developing a new facility in the Greater Washington DC area.
“It is a tribute to the entire Randox team, both in Co Antrim and Co Donegal, that we have been named as one of the US-Ireland Top 50. We hope to serve as an example to other aspiring businesses that success is possible with a unique product offering, a commitment to investment, and making use of the support network available across the United States.”
– ENDS –
Please contact Randox PR using the contact details below for more information: Ring 028 9442 2413 or email email@example.com
Image One: The US-Ireland Top 50 event logo
Image Two: Pictured at last year’s New York/New Belfast business and investment conference are (l-r) host Mairtin O Muilleoir (IRE), Senator Mary White (IRE), Christine Quinn (USA), JJ Magee (IRE) and New York City Council Members Elizabeth Crowley and Daniel Dromm (USA)
About Randox Laboratories
Randox is a global leader in healthcare diagnostics; today more than 5% of the world’s population – in excess of 370 million people across 145 countries – receives medical diagnosis using Randox products each year. Randox is the largest diagnostic company from the UK and exports over 95% of products worldwide. Our products and services are used in hospitals, clinical, research and molecular laboratories, food testing, forensic toxicology, life sciences, and veterinary laboratories.
With more than 1400 employees of 44 nationalities, including 300 research scientists and engineers, we have offices and distribution in over 145 countries. There are four key manufacturing and research and development sites, located in County Antrim, Northern Ireland; Dungloe, County Donegal, Ireland; Bangalore, India; and in the Greater Washington DC area, USA. Our Randox Health Clinics are currently located in London and Belfast, with ambitious plans to roll out a number of new clinics across the UK over 2016 – 2017.
With a major focus in R&D, Randox scientists work in pioneering research into a range of common illnesses such as cancer, cardiovascular disease and Alzheimer’s disease. With around 16% of turnover reinvested in R&D, Randox has more new tests in development than any other diagnostic company.
Our scientists have spent over £220 million researching the thousands of biomarkers present in our bodies and have identified the gold standard in testing. Our patented Biochip Array Technology is the world’s only diagnostic grade biochip. This state-of-the-art technology has revolutionised the diagnostics industry by offering a unique testing platform which allows multiple tests to be carried out from a single patient sample at our Randox Health Clinics.